| 产品详情 |
| Edit |   |
|---|
| Product Name | MDV-3100 |
|---|
| Description | MDV-3100 (Enzalutamide) is an androgen-receptor (AR) antagonist (IC50 = 36 nM). Prevents nuclear translocation and co-activator recruitment of the ligand-receptor complex. MDV 3100 has also been shown to induce tumor cell apoptosis, and has no agonist activity. MDV 3100 is a candidate for the treatment of castration-resistant prostate cancer. MW: 464.43. Purity ≥98% by HPLC |
|---|
| Size | 50 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 4-(3-(4-cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl)-2-fluoro-N-methylbenzamide; Enzalutamide |
|---|
| Gene, Accession, CAS # | CAS: 915087-33-1 |
|---|
| Catalog # | 9479-50 |
|---|
| Price | |
|---|
| Order / More Info | MDV-3100 from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|